No Antibiotic Treatment for Uncomplicated URTI
For uncomplicated upper respiratory tract infections (URTIs), the drug of choice is NO antibiotic—supportive care only with analgesics, antipyretics, and symptomatic relief measures. 1
Key Clinical Principle
The common cold and nonspecific URTIs are viral, self-limited illnesses where antibiotics provide no benefit and cause more harm than good. The number needed to harm (8) exceeds the number needed to treat (18) even when bacterial infection is present 1.
When Antibiotics Are NOT Indicated
Never prescribe antibiotics for:
- Common cold/nonspecific URTI
- Viral rhinitis
- Acute pharyngitis without confirmed Group A Streptococcus
- Symptoms lasting less than 10 days that are stable or improving 1, 2, 3
Critical Pitfall to Avoid
Purulent nasal discharge does NOT indicate bacterial infection and does NOT justify antibiotic use 2. This is commonly misunderstood—purulent secretions occur with viral URTIs due to inflammatory response, not bacterial superinfection.
Supportive Care Recommendations
Provide symptomatic relief with:
- Analgesics (acetaminophen, ibuprofen, naproxen) for pain/fever
- Antipyretics for fever control
- Saline nasal irrigation for congestion
- Topical or systemic decongestants as needed
- Intranasal corticosteroids for nasal symptoms
- Antihistamines only if allergic component present 1
When to Consider Antibiotics (Bacterial Rhinosinusitis)
Reserve antibiotics ONLY when clinical criteria suggest acute bacterial rhinosinusitis:
Three specific scenarios warrant antibiotics:
- Persistent symptoms >10 days without improvement
- Severe symptoms at onset: fever >39°C AND purulent nasal discharge or facial pain for ≥3 consecutive days
- "Double sickening": worsening symptoms after initial improvement from typical viral URI lasting 5+ days 1
If Antibiotics Are Indicated
When bacterial rhinosinusitis criteria are met:
First-line choice: Amoxicillin-clavulanate (per IDSA guidelines) 1
- Alternative societies recommend plain amoxicillin (AAFP, AAAAI) 1
- No direct evidence proves amoxicillin-clavulanate superiority, but IDSA recommends it for coverage of ampicillin-resistant H. influenzae and M. catarrhalis
Alternatives: Doxycycline or respiratory fluoroquinolone for penicillin allergy 1
Evidence Quality Note
The 2016 ACP/CDC guidelines 1 represent the highest quality evidence available, emphasizing that most antibiotic prescriptions for URTIs (approximately 30% of 37 million annual visits) are inappropriate and unnecessary 1. This guideline prioritizes reducing antibiotic-related adverse events and combating resistance while maintaining quality of life through effective symptom management.